Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
479,839
-
Shares change
-
-227,209
-
Total reported value, excl. options
-
$394,000
-
Value change
-
-$269,817
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$0.8234
Significant Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q2 2022
11 filings reported holding NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share as of Q2 2022.
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 479,839 shares
of 50,013,453 outstanding shares and own 0.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (239,391 shares), DRIVE WEALTH MANAGEMENT, LLC (66,667 shares), Kingsbury Capital Investment Advisors LLC (53,403 shares), Intersect Capital LLC (50,000 shares), GEODE CAPITAL MANAGEMENT, LLC (48,716 shares), NORTHERN TRUST CORP (15,376 shares), Tower Research Capital LLC (TRC) (5,405 shares), UBS Group AG (881 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), and Stonepine Capital Management, LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.